Clinical trial
Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or…
NCT00077129 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00077129 |
|---|---|
| Title | Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer |
| Official title | Phase II Trial Of Paclitaxel Plus Carboplatin In Patients With Metastatic Or Locally Advanced Collecting Duct Renal Cell Cancer |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, paclitaxel |
| Enrollment | 22 |
| Start date | Jun 1, 2006 |
| Primary completion | Aug 1, 2006 |
| First posted | Feb 11, 2004 |
| Last update posted | Jun 18, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: